HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia.

AbstractCONTEXT:
Disturbances in markers of cortical γ-aminobutyric acid neurotransmission are a common finding in schizophrenia. The nature of γ-aminobutyric acid neurotransmission (hyperpolarizing or depolarizing) depends on the local intracellular chloride concentration. In the central nervous system, the intracellular chloride level is determined by the activity of 2 cation-chloride transporters, NKCC1 and KCC2. The activities of these transporters are in turn regulated by a network of serine-threonine kinases that includes OXSR1, STK39, and the WNK kinases WNK1, WNK3, and WNK4.
OBJECTIVE:
To compare the levels of NKCC1, KCC2, OXSR1, STK39, WNK1, WNK3, and WNK4 transcripts in prefrontal cortex area 9 between subjects with schizophrenia and healthy comparison subjects.
DESIGN:
Real-time quantitative polymerase chain reaction technique was used to measure transcript levels in the prefrontal cortex.
SETTING:
Human brain specimens were obtained from autopsies conducted at the Allegheny County Medical Examiner's Office, Pittsburgh, Pennsylvania.
PARTICIPANTS:
Postmortem brain specimens from 42 subjects with schizophrenia and 42 matched healthy comparison subjects. Brain specimens from 18 macaque monkeys exposed to haloperidol, olanzapine, or sham long-term.
MAIN OUTCOME MEASURES:
Relative expression levels for NKCC1, KCC2, OXSR1, STK39, WNK1, WNK3, and WNK4 transcripts compared with the mean expression level of 3 housekeeping transcripts.
RESULTS:
OXSR1 and WNK3 transcripts were substantially overexpressed in subjects with schizophrenia relative to comparison subjects. In contrast, NKCC1, KCC2, STK39, WNK1, and WNK4 transcript levels did not differ between subject groups. OXSR1 and WNK3 transcript expression levels were not changed in antipsychotic-exposed monkeys and were not affected by potential confounding factors in the subjects with schizophrenia.
CONCLUSION:
In schizophrenia, increased expression levels, and possibly increased kinase activities, of OXSR1 and WNK3 may shift the balance of chloride transport by NKCC1 and KCC2 and alter the nature of γ-aminobutyric acid neurotransmission in the prefrontal cortex.
AuthorsDominique Arion, David A Lewis
JournalArchives of general psychiatry (Arch Gen Psychiatry) Vol. 68 Issue 1 Pg. 21-31 (Jan 2011) ISSN: 1538-3636 [Electronic] United States
PMID20819979 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Chlorides
  • Intracellular Signaling Peptides and Proteins
  • Minor Histocompatibility Antigens
  • RNA, Messenger
  • SLC12A1 protein, human
  • SLC12A2 protein, human
  • Sodium-Potassium-Chloride Symporters
  • Solute Carrier Family 12, Member 1
  • Solute Carrier Family 12, Member 2
  • OXSR1 protein, human
  • Protein Serine-Threonine Kinases
  • STK39 protein, human
  • WNK Lysine-Deficient Protein Kinase 1
  • WNK1 protein, human
  • WNK3 protein, human
  • WNK4 protein, human
Topics
  • Adult
  • Autopsy
  • Case-Control Studies
  • Chlorides (metabolism)
  • Diagnostic and Statistical Manual of Mental Disorders
  • Female
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Ion Transport (genetics)
  • Male
  • Middle Aged
  • Minor Histocompatibility Antigens
  • Prefrontal Cortex (metabolism)
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • RNA, Messenger
  • Reverse Transcriptase Polymerase Chain Reaction
  • Schizophrenia (genetics, metabolism)
  • Sodium-Potassium-Chloride Symporters (genetics, metabolism)
  • Solute Carrier Family 12, Member 1
  • Solute Carrier Family 12, Member 2
  • Up-Regulation (genetics)
  • WNK Lysine-Deficient Protein Kinase 1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: